ArticleInvestigational new drugs2013

Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas.

Tanja Trarbach et al.PubMed ↗Publisher ↗

No numbers read from the abstract.